Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yazeed Samara"'
Autor:
Joanna Zurko, Jeremy Ramdial, Mazyar Shadman, Sairah Ahmed, Aniko Szabo, Lorenzo Iovino, Ana Alarcon Tomas, Craig Sauter, Miguel-Angel Perales, Nirav. N. Shah, Utkarsh H. Acharya, Caron Jacobson, Robert J. Soiffer, Trent Wang, Krishna V. Komanduri, Samantha Jaglowski, Adam S. Kittai, Nathan Denlinger, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Julio Chavez, Michael Jain, Frederick L. Locke, Yazeed Samara, Lihua E. Budde, Matthew G. Mei, Alexandra Della Pia, Tatyana Feldman, Nausheen Ahmed, Ryan Jacobs, Nilanjan Ghosh, Bhagirathbhai Dholaria, Olalekan O. Oluwole, Brian Hess, Ayesha Hassan, Vaishalee P. Kenkre, Patrick Reagan, Farrukh Awan, Yago Nieto, Mehdi Hamadani, Alex F. Herrera
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Allogeneic hematopoietic cell transplantation (alloHCT) can potentially salvage large B-cell lymphoma (LBCL) patients experiencing treatment failure after chimeric antigen receptor T-cell therapy (CAR T). Nonetheless, data on the efficacy and toxicit
Externí odkaz:
https://doaj.org/article/79e2386110cd4911812ba846c2081e54
Autor:
Yazeed Samara, Matthew Mei
Publikováno v:
Cancers, Vol 14, Iss 7, p 1738 (2022)
Standard treatment for relapsed and/or refractory (r/r) Hodgkin lymphoma (HL) consists of salvage therapy, historically consisting of multiagent cytotoxic chemotherapy, followed by autologous stem cell transplantation (autoHCT) in responding patients
Externí odkaz:
https://doaj.org/article/b72fb7233ba24057bf63424f8b1a39d1
Autor:
Janny M. Yao, Salman Otoukesh, Hanna Kim, Dongyun Yang, Sally Mokhtari, Yazeed Samara, Amanda Blackmon, Shukaib Arslan, Vaibhav Agrawal, Hoda Pourhassan, Idoroenyi Amanam, Brian Ball, Paul Koller, Amandeep Salhotra, Pamela Becker, Peter Curtin, Andrew Artz, Ibrahim Aldoss, Haris Ali, Forrest Stewart, Eileen Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Joanna C Zurko, Jeremy Ramdial, Sairah Ahmed, Aniko Szabo, Lorenzo Iovino, Mazyar Shadman, Utkarsh H. Acharya, Caron A. Jacobson, Robert J. Soiffer, Trent P Wang, Krishna V. Komanduri, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Yazeed Samara, Alexandra Della Pia, Tatyana Feldman, Nausheen Ahmed, Ryan Jacobs, Nilanjan Ghosh, Bhagirathbhai Dholaria, Olalekan O. Oluwole, Brian Hess, Yago Nieto, Mehdi Hamadani, Alex F. Herrera
Publikováno v:
Transplantation and Cellular Therapy. 28:S7-S9
Autor:
Amrita Desai, Dongyun Yang, Brian Ball, Paul Koller, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Yazeed Samara, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Monzr M. Al Malki, Andrew S. Artz, Pamela S. Becker, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Peter Curtin, Ryotaro Nakamura, Vinod Pullarkat
Publikováno v:
Transplantation and Cellular Therapy. 29:S102
Autor:
Mazyar Shadman, Allison M. Winter, Yazeed Samara, Paolo Caimi, Ryan C. Lynch, Stephen D. Smith, Brian T. Hill, Caron A. Jacobson, Matthew Mei, Alex F. Herrera, Filippo Milano, Ajay K. Gopal, Chaitra S. Ujjani, Paolo Lopedote, Austin I. Kim
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:170-175
Polatuzumab vedotin is approved therapy in the United States for relapsed/refractory diffuse large B-cell lymphoma in combination with bendamustine and rituximab (Pola+BR). However, the safety and efficacy of Pola+BR outside of a clinical trial setti
Autor:
Sarah Tomassetti, Yazeed Samara, Katie LaBarbera, Xin Qing, Richa Rathore, Alexey Aleshin, Laron McPhaul
Publikováno v:
Journal of Clinical Oncology. 40:e19552-e19552
e19552 Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. With upfront treatment, 40% of patients relapse. Currently, treatment response and surveillance are monitored using positron emission tomography/computerize
Publikováno v:
ACG Case Reports Journal. 9:e00764
Autor:
Joanna Zurko, Jeremy Ramdial, Mazyar Shadman, Sairah Ahmed, Aniko Szabo, Lorenzo Iovino, Ana Alarcon Tomas, Craig Sauter, Miguel-Angel Perales, Nirav. N. Shah, Utkarsh H. Acharya, Caron Jacobson, Robert J. Soiffer, Trent Wang, Krishna V. Komanduri, Samantha Jaglowski, Adam S. Kittai, Nathan Denlinger, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Julio Chavez, Michael Jain, Frederick L. Locke, Yazeed Samara, Lihua E. Budde, Matthew G. Mei, Alexandra Della Pia, Tatyana Feldman, Nausheen Ahmed, Ryan Jacobs, Nilanjan Ghosh, Bhagirathbhai Dholaria, Olalekan O. Oluwole, Brian Hess, Ayesha Hassan, Vaishalee P. Kenkre, Patrick Reagan, Farrukh Awan, Yago Nieto, Mehdi Hamadani, Alex F. Herrera
Publikováno v:
Haematologica. 108(1)
Allogeneic hematopoietic cell transplantation (alloHCT) can potentially salvage large B-cell lymphoma (LBCL) patients experiencing treatment failure after chimeric antigen receptor T-cell therapy (CAR T). Nonetheless, data on the efficacy and toxicit
Autor:
Yazeed Samara, Farhad M Limonadi, Omid Hamid, Constantin A Dasanu, Ion Codreanu, Juliana Alvarez-Argote
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(3)
Effective therapies for relapsed/refractory meningioma after surgery and radiation therapy represent an unmet need. Most meningiomas are highly vascularized tumors and, therefore, potentially amenable to antiangiogenic therapy. Herein, we review comp